rna
interfer
rnai
conserv
mechan
trigger
small
interf
rna
sirna
use
suppress
gene
express
rna
degrad
replic
calicivirus
cv
rnai
studi
use
tulan
viru
tv
model
five
sirna
target
nonstructur
major
minor
structur
gene
tv
develop
virus
quantifi
use
qpcr
tcid
assay
treatment
cell
sirna
hour
viral
inocul
significantli
reduc
viral
titer
log
dramat
decreas
viral
rna
copi
number
viral
titer
hour
post
infect
four
five
sirna
studi
result
confirm
western
blot
major
structur
protein
markedli
reduc
cell
cultur
medium
two
small
protein
band
p
domain
viral
capsid
protein
also
detect
cell
lysat
although
role
viral
replic
remain
unknown
sinc
tv
share
mani
biolog
properti
human
norovirus
nov
success
demonstr
rnai
tv
replic
would
provid
valuabl
inform
control
acut
gastroenter
caus
human
nov
norovirus
nov
belong
caliciviru
cv
famili
small
nonenvelop
singl
strand
positivesens
rna
virus
nov
lead
caus
epidem
nonbacteri
acut
gastroenter
affect
million
peopl
worldwid
virus
spread
fecalor
pathway
persontoperson
contact
contamin
environment
surfac
water
food
highli
contagi
usual
result
larg
outbreak
crowd
commun
institut
school
restaur
hospit
child
care
center
nurs
home
elderli
cruiseship
militari
set
accord
recent
estim
nov
caus
episod
diarrhea
requir
hospit
clinic
visit
among
children
industri
countri
inpati
hospit
death
children
age
five
develop
countri
patel
et
al
nov
also
lead
caus
foodborn
ill
attribut
million
case
unit
state
annual
hall
et
al
human
nov
difficult
studi
due
lack
cell
cultur
proper
anim
model
nov
recent
cultiv
monkey
enter
caliciviru
tulan
viru
tv
isol
could
use
surrog
human
nov
tv
genet
close
relat
nov
caliciviru
genera
tv
also
recogn
histoblood
group
antigen
hbga
like
human
nov
farka
et
al
complet
genom
tv
organ
three
open
read
frame
orf
similar
nov
compos
twothird
genom
encod
nonstructur
ns
polyprotein
autocleav
least
six
function
unit
includ
ntermin
protein
ntpase
small
protein
yet
unknown
function
vpg
viral
proteas
rnadepend
rna
polymeras
rdrp
ntpase
rdrp
play
essenti
role
viral
rna
replic
tao
ye
encod
major
structur
protein
encod
minor
structur
protein
hardi
rna
interfer
rnai
molecular
mechan
fragment
doublestrand
small
interf
rna
sirna
interfer
express
particular
gene
mediat
degrad
mrna
elbashir
et
al
gitlin
et
al
li
et
al
sinc
discoveri
sirna
new
field
drug
discoveri
emerg
wide
varieti
human
diseas
cancer
haasnoot
et
al
urbanklein
et
al
grzelinski
et
al
haasnoot
berkhout
ahn
et
al
palumberi
et
al
metabol
diseas
viral
infect
leonard
schaffer
rossi
ding
haasnoot
berkhout
number
studi
success
demonstr
sirna
abl
effect
inhibit
viral
replic
infect
includ
sar
li
et
al
wu
et
al
respiratori
syncyti
viru
tripp
alvarez
et
al
rotaviru
dector
et
al
aria
et
al
ebola
viru
geisbert
et
al
hiv
morri
rossi
influenza
viru
ge
et
al
ge
et
al
dengu
viru
travanti
et
al
wu
et
al
polioviru
saleh
et
al
hepat
b
c
virus
saulnier
et
al
panjaworayan
et
al
pelleti
et
al
studi
sirna
design
evalu
inhibit
cv
replic
cell
cultur
use
tv
model
five
sirna
duplex
design
target
differ
gene
tv
genom
signific
reduct
tv
replic
observ
follow
treatment
four
five
sirna
futur
studi
optim
deliveri
sirna
requir
tv
use
experi
maintain
laboratori
passag
sinc
origin
isol
rhesu
macaqu
stool
sampl
monkey
kidney
cell
atcc
use
cultiv
tv
two
hyperimmun
antibodi
shell
protrud
p
domain
tv
capsid
protein
respect
develop
use
recombin
p
domain
protein
describ
p
domain
tv
capsid
protein
tvpd
code
cdna
clone
vector
qiagen
maryland
md
rtpcr
primer
pair
contain
bamh
hind
iii
site
cgcggatccaatgcactgccaatttggtcc
cccaagcttttatctaaagacaactgcctgcag
recombin
tvpd
protein
histag
express
e
coli
mm
iptg
room
temperatur
overnight
due
low
solubl
tvpd
protein
purif
tvpd
protein
perform
denatur
condit
use
talon
metal
affin
resin
bd
franklin
lake
nj
usa
briefli
e
coli
cell
suspend
equilibr
buffer
contain
mm
sodium
phosphat
guanidinehcl
mm
nacl
sonic
min
centrifug
g
min
solubl
tvpd
histag
fusion
protein
purifi
talon
resin
elut
imidazol
elut
buffer
contain
guanidin
concentr
guanidin
reduc
dialysi
antibodi
induct
code
region
tv
domain
amplifi
primer
pair
contain
ecor
xho
site
aatgaattcatggaaaacagcaaaactg
ctgctcgagttatctaaagacaactgc
clone
vector
ge
healthscienc
pittsburgh
pa
gsttvsd
fusion
protein
express
e
coli
plyss
novagen
darmstadt
germani
mm
iptg
overnight
room
temperatur
cell
harvest
centrifug
g
min
resuspend
pb
contain
mm
phenylmethylsulfonyl
fluorid
pmsf
cell
suspens
subject
sonic
clarif
centrifug
g
min
gstfusion
protein
supernat
purifi
affin
chromatographi
use
glutathion
sepharos
resin
ge
healthcar
pittsburgh
pa
gsttag
remov
digest
fusion
protein
thrombin
purifi
gel
filtrat
chromatographi
use
superdex
column
ge
healthcar
pittsburgh
pa
mous
antitvpd
antibodi
rabbit
antitvsd
polycolon
antibodi
gener
follow
anim
immun
two
protein
use
procedur
describ
previous
tan
et
al
tv
genom
sequenc
use
templat
design
sirna
duplex
five
sirna
target
differ
structur
nonstructur
gene
tv
genom
design
use
webbas
sidesign
program
dharmacon
inc
thermo
scientif
rockford
il
sirna
contain
nt
doublestrand
rna
plu
uu
overhang
end
strand
rna
figur
sirna
synthes
dharmacon
sigenom
nontarget
sirna
also
purchas
dharmacon
neg
control
cell
cultur
medium
mediatech
manassa
va
supplement
heatinactiv
fetal
bovin
serum
unitml
penicillin
ml
streptomycin
maintain
co
transfect
sirna
perform
well
plate
mm
dish
cell
confluenc
describ
previous
fan
et
al
briefli
sirna
duplex
pmol
mix
lipofectamin
invitrogen
carisbad
ca
mixtur
appli
cell
four
hour
post
transfect
cell
infect
tv
multipl
infect
moi
one
hour
slight
rock
ensur
everi
cell
infect
infect
cell
wash
four
time
pb
medium
remov
viru
left
media
ad
new
cultur
media
fb
infect
cell
cultur
maintain
hour
score
antivir
effect
cpe
tcid
qrtpcr
western
blot
assay
viral
titer
supernat
cell
determin
titrat
use
cpebas
tissu
cultur
infect
dose
tcid
assay
collect
cultur
media
spun
g
min
serial
dilut
viru
suspens
ad
cell
well
plate
replic
well
prepar
dilut
cell
check
daili
cpe
result
score
day
dpi
ge
et
al
qpcr
perform
use
icycl
iq
biorad
real
time
pcr
detect
system
total
viral
rna
tv
cell
cultur
media
extract
use
qiaamp
viral
rna
mini
kit
qiagen
maryland
md
rna
yield
determin
spectrophotomet
nanodrop
technolog
inc
wilmington
de
revers
transcript
rt
carri
use
goscript
revers
transcript
system
promega
san
lui
obispo
ca
reation
mixtur
contain
ng
total
rna
oligo
dt
primer
accord
manufactur
instruct
aliquot
rt
reaction
mixtur
use
qpcr
reaction
use
sybr
green
pcr
method
biorad
hercul
ca
qpcr
perform
min
anoth
sec
min
cycl
post
amplif
melt
curv
analysi
perform
confirm
product
specif
reaction
reaction
done
duplic
analyz
icycl
iq
softwar
version
biorad
viral
rna
copi
number
sampl
convert
base
ct
valu
sampl
compar
standard
curv
total
tv
rna
known
copi
number
use
viral
replic
normal
tv
infect
control
pcr
primer
use
detect
rrna
endogen
control
rev
primer
pair
detect
tv
genom
rev
genom
oligo
dt
agtagcctcgagcggccgttttttttttttttt
use
tv
infect
cell
analyz
tv
capsid
p
protein
western
blot
analysi
brief
total
protein
cell
cultur
supernat
harvest
hpi
major
cell
remain
attach
cell
wash
pb
lyse
ripa
buffer
thermo
sci
rockford
il
contain
pmsf
aprotinin
leupeptin
total
protein
cell
cultur
supernat
harvest
centrifug
g
optima
ultracentrifug
beckman
coulter
brea
ca
h
pellet
resuspend
ripa
buffer
mention
equival
volum
cell
lysat
cultur
supernat
prepar
sampl
analyz
sdspage
western
blot
analysi
protein
transfer
nitrocellulos
firstli
detect
p
domain
protein
use
mous
antitvpd
antibodi
follow
hrplink
secondari
antibodi
mp
biomed
llc
solon
oh
signal
detect
hyglo
chemiluminesc
hrp
antibodi
detect
reagent
denvil
scientif
inc
metuchen
nj
detect
domain
protein
membran
strip
strip
buffer
thermo
sci
rockford
il
incub
rabbit
anti
tvsd
antibodi
detect
hrplink
antibodi
potenti
kda
cellular
protein
stain
p
domain
specif
antibodi
origin
gel
use
load
control
signal
faint
twice
strip
treatment
perform
triplic
result
express
mean
sd
three
independ
experi
data
analyz
use
pair
ttest
statist
signific
defin
p
initi
experi
four
sirna
target
nonstructur
gene
ntpase
rdrp
major
minor
structur
gene
tv
genom
respect
design
three
sintpas
sirdrp
reveal
signific
interfer
tv
replic
one
target
major
structur
gene
much
less
effici
verifi
result
anoth
sirna
target
differ
locat
gene
design
compar
interfer
effect
observ
three
sirna
figur
condit
effect
transfect
sirna
host
cell
evalu
base
morpholog
host
cell
monolay
outcom
cpe
follow
sirna
transfect
viral
infect
dose
pmol
sirna
select
five
sirna
studi
caus
visual
cytotox
protect
clearli
viral
infect
llcmk
cell
ratio
sirna
transfect
reagent
use
deliv
sirna
host
cell
also
determin
base
previou
experi
fan
et
al
pilot
result
data
shown
good
cell
morpholog
high
effici
rnai
obtain
addit
interv
transfect
sirna
viral
inocul
select
result
clear
antivir
effect
within
hour
post
infect
hpi
furthermor
effect
multipl
deliveri
differ
sirna
simultan
sirna
repeatedli
viral
replic
also
evalu
signific
enhanc
antivir
effect
found
either
approach
thu
subsequ
experi
one
dose
sirna
use
optim
transfect
condit
hour
viral
inocul
use
cell
cultur
maintain
hpi
score
viral
replic
qrtpcr
tcid
western
blot
analysi
hpi
final
primer
pair
tv
genom
use
qpcr
signific
differ
two
primer
pair
found
detect
tv
cell
cultur
data
shown
sinc
pair
would
like
detect
fulllength
genom
compar
pair
select
subsequ
experi
describ
four
five
sirna
result
appar
protect
tv
replic
cell
typic
cpe
round
detach
cell
float
around
seen
hpi
well
control
sirna
well
four
sirna
data
shown
well
without
tv
infect
cpe
much
clearer
hpi
cell
transfect
sicontrol
round
detach
chang
well
figur
evalu
antivir
effect
sirna
tv
infect
amount
viral
rna
cell
cultur
supernat
measur
real
time
rtpcr
hpi
viral
copi
number
supernat
infect
cell
dramat
reduc
time
point
viral
titer
continu
increas
hpi
well
contain
sicontrol
figur
antivir
effect
seem
much
stronger
nonstructur
sirna
sintpas
sirdrp
measur
hpi
p
hpi
p
low
level
viral
reduct
seen
hpi
reduct
seen
hpi
antivir
effect
evalu
cpebas
tcid
analysi
outcom
correl
qrtpcr
result
well
signific
reduct
tcid
observ
four
sirna
hpi
antivir
effect
seem
highest
sintpas
estim
log
tcid
reduct
observ
supernat
cell
treat
sintpas
hpi
figur
confirm
antivir
effect
sirna
tv
western
blot
analysi
tv
structur
protein
perform
virus
harvest
infect
cell
cell
cultur
supernat
hpi
result
confirm
qrtpcr
tcid
data
signific
decreas
express
viral
capsid
protein
detect
cell
treat
four
sirna
sintpas
sirdrp
cell
treat
use
p
domain
specif
antibodi
figur
virus
remain
cell
associ
signal
full
length
insid
cell
much
stronger
supernat
figur
interestingli
two
small
protein
band
besid
full
length
also
detect
p
domain
specif
antibodi
respect
accord
molecular
weight
two
protein
around
kda
kda
like
cleav
product
repres
p
domain
viral
capsid
protein
figur
b
detect
p
protein
stool
sampl
nov
infect
patient
report
greenberg
et
al
graham
et
al
although
function
protein
viral
replic
pathogenesi
remain
unknown
knowledg
first
time
detect
protein
cv
futur
studi
need
determin
side
product
viral
capsid
biolog
function
viral
replic
andor
pathogenesi
host
studi
effect
rnai
inhibit
viral
replic
potenti
treatment
nov
demonstr
use
tv
cell
cultur
model
current
result
show
sirna
target
either
nonstructur
structur
gene
tv
genom
highli
effect
reduct
tv
replic
cell
effect
inhibit
caliciviru
replic
antisens
rna
also
observ
felin
cv
stein
et
al
murin
noroviru
mnv
bok
et
al
antivir
effect
determin
qrtpcr
tcid
confirm
western
blot
analys
one
dose
sirna
deliv
four
hour
viral
inocul
highli
effect
control
tv
replic
least
hpi
log
tcid
reduct
effect
sirna
target
viral
ntpase
gene
studi
also
show
antivir
activ
mediat
sirna
genom
locationdepend
andor
gene
sequencedepend
zheng
et
al
mcdonagh
et
al
siu
et
al
exampl
two
sirna
duplex
target
viral
nonstructur
protein
ntpase
rdrp
respect
potent
inhibit
effect
tv
replic
although
function
ntpase
remain
unclear
tv
studi
flaviviru
shown
function
inhibit
ntpase
may
occur
competit
blockad
ntp
bind
site
conform
chang
immobil
switch
region
competit
inhibit
rna
bind
inhibit
unwind
via
steric
blockad
transloc
ntpase
along
templat
rna
borowski
et
al
borowski
et
al
rdrp
involv
synthesi
genom
subgenom
rna
essenti
caliciviru
replic
thu
select
sirna
target
nonstructur
gene
may
choic
target
highli
effici
rnai
cv
reason
lack
inhibit
tv
replic
first
sirna
target
gene
remain
unknown
although
one
point
mutat
found
tv
genom
target
region
base
recent
sequenc
result
data
shown
could
caus
failur
still
exclud
caus
rel
ineffect
howev
success
antivir
effect
second
sirna
target
differ
region
gene
well
sirna
target
gene
suggest
viral
structur
gene
could
also
good
target
rnai
caliciviru
although
differ
find
other
report
zheng
et
al
rel
less
effici
structur
sirna
comparison
nonstructur
sirna
could
due
potenti
high
copi
number
structur
gene
nonstructur
gene
structur
gene
encod
genom
subgenom
rna
hardi
also
studi
time
treatment
combin
sirna
reduct
tv
potenti
clinic
applic
rnai
gener
singl
dose
sirna
four
hour
viral
inocul
found
suffici
prevent
tv
replic
least
hour
result
consist
fact
clear
addit
effect
addit
dose
sirna
later
time
within
hour
period
necessari
multipl
dose
treatment
experi
data
shown
howev
slight
increas
effici
use
combin
one
sirna
compar
one
singl
sirna
singl
dose
treatment
inde
observ
combin
sirna
target
nonstructur
gene
ntpase
rdrp
half
dosag
seem
effect
combin
sirna
target
structur
nonstructur
gene
data
shown
one
dose
seem
control
tv
infect
suffici
hour
futur
studi
extend
cours
diseas
may
necessari
ill
nov
gastroenter
usual
last
day
even
longer
viral
shed
week
may
requir
altern
model
almost
cell
sicontrol
infect
round
detach
might
longer
suscept
tv
detect
p
domain
protein
tv
infect
cell
unexpect
particularli
protein
never
report
other
sinc
solubl
p
protein
also
found
stool
specimen
nov
infect
patient
greenberg
et
al
graham
et
al
hardi
et
al
could
certain
biolog
function
viral
replic
pathogenesi
find
protein
insid
cell
cultur
medium
supernat
indic
neither
protein
fragment
part
matur
virion
suggest
function
p
protein
includ
involv
host
receptor
recognit
immun
regul
tan
et
al
tan
et
al
chen
et
al
tan
et
al
hand
still
exclud
possibl
two
protein
fragment
random
degrad
product
particularli
molecular
weight
protein
seen
western
blot
analysi
bigger
expect
kda
base
predict
hing
region
tv
genom
previou
studi
detect
p
protein
stool
use
serum
sampl
nov
infect
patient
greenberg
et
al
graham
et
al
might
abl
detect
domain
protein
studi
use
domain
antibodi
rais
recombin
protein
thu
p
domain
fragment
could
natur
degrad
product
without
function
viral
replic
summari
studi
demonstr
feasibl
sirna
tv
replic
may
valuabl
prophylact
therapeut
treatment
caliciviru
particularli
nov
although
singl
dose
four
hour
viral
infect
demonstr
effect
inhibit
tv
still
long
way
go
approach
use
clinic
practic
treat
prevent
nov
gastroenter
major
challeng
includ
procedur
deliv
drug
host
cell
maintain
appropri
concentr
sirna
fight
virus
genet
variat
nov
anoth
challeng
broad
protect
differ
nov
final
appropri
anim
model
assess
efficaci
treatment
exist
requir
continu
effort
futur
studi
genom
organ
tv
locat
sirna
tv
genom
bp
encod
larg
nonstructur
polyprotein
major
minor
structur
protein
three
open
read
frame
orf
locat
sirna
target
nonstructur
sintpas
sirdrp
gene
indic
morpholog
chang
cell
follow
tv
infect
without
treatment
sirna
cell
cultur
imag
hpi
typic
cpe
appear
round
detach
float
cell
seen
well
transfect
sicontrol
cell
treat
sintpas
sirdrp
reveal
round
cell
cpe
similar
uninfect
cell
without
transfect
reagent
ct
valu
sirna
treatment
uninfect
treatment
normal
use
calcul
signific
differ
individu
treatment
sicontrol
indic
p
p
rel
viru
yield
tcid
media
hpi
viral
titer
treatment
sirna
measur
day
post
infect
signific
differ
individu
treatment
sicontrol
indic
p
p
western
blot
analysi
tv
capsid
protein
cell
follow
treatment
sirna
cell
harvest
hpi
total
protein
cell
lysat
b
cultur
supernat
c
analyz
electrophoresi
follow
detect
tv
p
domain
c
domain
b
antibodi
blot
detect
p
domain
antibodi
first
domain
antibodi
strip
locat
truncat
p
domain
protein
indic
nonspecif
band
around
kda
origin
gel
use
load
control
assay
lane
tv
lane
sicontrol
lane
sintpas
lane
sirdrp
lane
lane
lane
